08/20/2024
Hogan Lovells advises MorphoSys on its delisting from the stock exchange and the public delisting tender offer by Novartis
The delisting tender offer by Novartis, which was offered to all MorphoSys shareholders to acquire their MorphoSys shares against payment of a cash consideration of EUR 68.00 per MorphoSys share